GlassScriptPhysician profile
George T Keith
NPI 1598748873
$22,637.69
in general payments reported to CMS, 2019-2025
52 companies · $3,912 in 2025
The $3,912 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,991 · 2020: $2,390 · 2021: $2,878 · 2022: $3,413 · 2023: $3,543 · 2024: $3,511 · 2025: $3,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $13.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,952.45 |
| Education | $13.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,505.80 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $3,340.44 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,811.07 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Actelion Pharmaceuticals US, INC. | $1,517.40 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $1,327.89 | 2019-2025 | Prolastin-C Liquid |
| Philips North America LLC | $1,015.50 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy, Home Pi Undivided |
| Electromed, INC. | $975.26 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $867.67 | 2019-2025 | Dupixent |
| Genzyme Corporation | $851.28 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $763.18 | 2020-2025 | Acthar |
| Mylan Specialty L.P. | $572.74 | 2019-2024 | Yupelri |
| Insmed, INC. | $547.26 | 2019-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $503.23 | 2019-2025 | |
| Harmony Biosciences LLC | $490.43 | 2022-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $456.17 | 2020-2025 | Aralast, Glassia |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $420.21 | 2019-2023 | Tyvaso, Orenitram |
| Genentech USA, INC. | $396.89 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $367.63 | 2019-2025 | |
| Axsome Therapeutics, INC. | $309.81 | 2023-2025 | Sunosi |
| Amgen INC. | $286.14 | 2022-2025 | Tezspire, Tavneos |
| Verona Pharma, INC. | $211.62 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $196.84 | 2019-2022 | |
| Intuitive Surgical, INC. | $190.48 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $171.12 | 2022-2025 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $129.21 | 2021-2022 | |
| Viatris Specialty LLC | $127.19 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $124.71 | 2022-2024 | Winrevair |
| Inspire Medical Systems, INC. | $124.65 | 2024-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $121.85 | 2024-2025 | Lumryz |
| Circassia INC. | $104.64 | 2019-2020 | |
| Inogen, INC. | $97.18 | 2020-2025 | Inogen One G3 Oxygen Concentrator |
| Shire North American Group INC | $77.64 | 2019 | |
| Tactile Systems Technology INC | $77.52 | 2024 | Entre Plus, Flexitouch Plus |
| Mallinckrodt Enterprises LLC | $58.98 | 2019 | |
| Gilead Sciences, INC. | $51.50 | 2019 | |
| Optinose US, INC. | $43.58 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $42.79 | 2022-2024 | Nuzyra |
| Phadia US INC. | $41.31 | 2021-2024 | Immunocap |
| Novartis Pharmaceuticals Corporation | $38.17 | 2019 | |
| Exact Sciences Corporation | $29.12 | 2023 | Cologuard Collection Kit |
| 3b Medical, INC. | $28.32 | 2024 | Luna |
| Sanofi US Services INC. | $25.14 | 2024 | |
| Sanofi-Aventis U.S. LLC | $24.70 | 2021 | |
| Biogen, INC. | $22.34 | 2024 | Skyclarys |
| Vapotherm INC | $21.83 | 2022 | |
| Pulmonx Corporation | $21.62 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Vanda Pharmaceuticals INC. | $21.61 | 2020 | |
| Novo Nordisk INC | $20.68 | 2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $20.22 | 2023 | Mounjaro |
| Resmed Corp | $17.40 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.53 | 2023 | Quviviq |
| Shionogi INC | $13.20 | 2024 | Fetroja |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.